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Background: A polymorphism in position 129 in 
the human prion protein modulates susceptibility 
to prion infection and disease phenotype. 
Results: Mutations to various amino acids 
highlights the importance of position 129 during 
amyloid fibrillation. 
Conclusion: Position 129 is a key site for early 
intermolecular interactions during fibrillation. 
Significance: Insight into early mechanisms of 
aggregation implicates a means to prevent 
fibrillation 
 
 
SUMMARY 
The role of the polymorphism 129M/V in the 
human prion protein is well documented 
regarding disease susceptibility and clinical 
manifestations. Little is however known about 
the molecular background to this phenomenon. 
We herein investigated the conformational 
stability, amyloid fibrillation kinetics and 
seeding propensity of different 129-mutants, 
located in -strand 1 of PrP (129M (wt), 129A, 
129V, 129L, 129W, 129P, 129E, 129K and 
129C) in HuPrP90-231. The mutations 129V, 
129L, 129K and 129C did not affect stability 
(midpoints of thermal denaturation, Tm =65-66 
°C), whereas the mutants 129A and 129E and 
the largest side chain 129W were destabilized 
by 3-4 °C. The most destabilizing substitution 
was 129P which lowered the Tm by 7.2 °C. All 
mutants, except 129C, formed amyloid like 
fibrils within hours during fibril formation 
under near physiological conditions. Fibril 
forming mutants, showed a sigmoidal kinetic 
profile and showed shorter lag times during 
seeding with preformed amyloid fibrils 
implicating a nucleated polymerization 
reaction. In the spontaneous reactions, the lag 
time of fibril formation was rather uniform for 
the mutants 129A, 129E, 129V, and 129L  
resembling the wild type 129M. When the 
substituted amino acid had a distinct feature 
discriminating it from the wild type, such as size 
(129W), positive charge (129K) or rotational 
constraint (129P), the fibrillation was impeded. 
129C did not form ThT/Congo red positive 
fibrils and non-reducing SDS PAGE of 129C 
during fibrillation conditions at different time 
points revealed covalent dimer formation 
already 15 minutes after fibrillation reaction 
initiation. Position 129 appears to be a key site 
for dictating PrP receptiveness towards 
recruitment into the amyloid state. 
 
 
The prion protein (PrP) is most abundant in 
mammalian neurons but is ubiquitously expressed 
throughout various cells and tissues. The 
functional role of native PrP is not fully 
understood. PrP is associated with a number of 
different prionoses, both sporadic, inherited and 
acquired, all of which are invariably fatal. The 
common molecular pathognomonic marker for 
prionoses is the presence of severe vacuolation 
within the CNS rendering a sponge like tissue. 
Concomitant with the presence of spongiosis is the 
presence of a conformational isoform of PrP, 
which has converted from  a largely helical 
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globular protein PrPC that misfold into an 
aggregation prone beta-sheet conformation, PrPSc, 
that often assemble into protein deposits with 
conspicuous similarities to amyloid (1). 
Several inherited prion disease-causing point 
mutations are found in the human PrP gene 
(PRNP) (2,3). There  are also two nonpathogenic 
polymorphisms, methionine or valine in position 
129  (M129V) and glutamic acid or lysine at codon 
219 (E219K) (4,5). These polymorphisms are not 
directly pathogenic but on the contrary 
hetrozygosity at either of these positions is 
associated with resistance to sporadic Creutzfeldt-
Jakob disease (sCJD) (6,7). The polymorphism in 
position 129 is also associated with sporadic 
Creutzfeldt-Jakob disease phenotype and 
influences the molecular type of prion strains (8). 
Furthermore, differences in codon 129 determine 
the phenotype of patients suffering pathogenic 
mutations elsewhere in the PRNP gene (9-13). 
Homozygous individuals are more susceptible to 
acquired prion disease such as Kuru, variant CJD 
and iatrogenic CJD (14-19).  
Taken together there is ample evidence that 
position 129 in PrP is a key site for prion disease 
susceptibility and hence most likely for PrP 
misfolding. The effect of the natural polymorphism 
at position 129 has been studied in vitro in several 
studies regarding both amyloid fibrillation kinetics 
and oligomerization. Reorganization of HuPrP90-231 
into mature amyloid fibrils under denaturing 
conditions is enhanced if position 129 encodes a 
valine while  methionine in this position favors 
formation of soluble oligomers (20-22).  
Amyloid fibril formation is a multiordered, 
nucleation dependent process (23). Because 
nucleation is a multiorder reaction its rate 
especially at low protein concentrations should be 
stochastic. This feature is reflected by a time 
variation of the lag phase of fibril formation (24). 
During amyloidogenesis, the fibril elongates 
through monomer addition and conversion and in 
addition the fibril is fragmented leading to 
multiplication of fibril elongation sites. It is hence 
evident that fragmentation of amyloid fibrils is of 
great importance for fibril replication. The rate of 
the growth phase is a measure of fibril fragility 
rather than of cooperativity in monomer addition 
(25-27).  
The amyloid formation pathways of many proteins 
involve formation of oligomeric species. These 
oligomers comprise varying numbers of non-native 
protein molecules, but most often they do not 
display the features of amyloid regarding ThT 
fluorescence. It has been shown that oligomers of 
many proteins involved in neurodegenerative 
diseases are the most toxic species in cell culture 
(28,29) including the prion protein (30,31). PrP 
forms oligomers via different pathways giving rise 
to different distinctly different oligomers from the 
same primary structure (32). The formation of 
different oligomers can also be modulated by the 
polymorphism in position 129. The propensity to 
form oligomers and the properties of the oligomers 
are not affected by the polymorphism, but the 
stacking of oligomers was suggested to be 
aggravated by the valine residue (33). 
In our current study we elucidated the 
conformational stability and amyloid propensity of 
recombinant HuPrP90-231 with variations in position 
129. We made use of the range of properties 
offered by amino acid substitution. To investigate 
the role of increasing number of methyl groups, 
alanine, valine and leucine were used. To elucidate 
the role of the sulfur atom in the wild type 
methionine, cysteine was included in the study. 
Lysine and glutamic acid should give information 
on the involvement of electrostatic interactions. 
Tryptophan was employed to examine influence of 
bulkiness. Proline was used to investigate how 
rotational constraint influences amyloid formation.  
 
EXPERIMENTAL PROCEDURE 
Expression and Purification of HuPrP90-231 and 
HuPrP121-231 - Plasmids (pREST A) containing 
HuPrP wt (129M) genes of desired lengths were 
obtained from K. Wüthrich (34). Site directed 
mutagenesis was performed using the QuikChange 
mutagenesis kit (Stratagene, La Jolla, CA, USA) 
according to manufacturer’s guide lines and 
mutants were verified by DNA sequencing (GATC 
biotechnology, Konstanz, Germany). The plasmids 
were transformed into BL21/DE3 cells and were 
grown on plates overnight. The cells were 
transferred to 1.5 l Terrific Broth (MP 
biochemicals) supplemented with 100 μg/ml 
ampicillin at 37ºC with shaking. At OD600~2.5 
isopropyl β-D-galactopyranoside was added to a 
final concentration of 1.5 mM to induce protein 
production. Agitation at 37 ºC was maintained 
during protein expression and cells were harvested 
by centrifugation after overnight induction, the 
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pellet was resuspended in buffer G (6 M guanidine 
hydrochloride, 10 mM Tris-HCl, pH 8.0, 100 mM 
Na2PO4, 10 mM reduced glutathione) and frozen 
at -80ºC until needed.  
After thawing, sonication and centrifugation, the 
soluble fraction was added to Ni-NTA-agarose 
(Qiagen) in a disposable column (3 ml). The 
agarose was washed with 10 ml buffer G, 7 ml 
50% buffer G and 50% buffer B (10 mM Tris-HCl, 
100 mM Na2PO4, pH 8.0), 5 ml Buffer B and 
finally 5 ml Buffer B supplemented with 50 mM 
imidazole. The protein was eluted using 10 ml 
Buffer E (10 mM Tris-HCl, 100 mM Na2PO4, 500 
mM imidazole pH 5.8). The washing procedure 
was repeated until the elution fractions no longer 
contained protein detectable by the Bradford assay 
(BioRad). The elution fractions were pooled, 
concentrated and applied to a Hiload 16/60 
superdex 75 prep grade column (GE Healthcare) 
using a BioLogic LP system (BioRad) with a 
continues flow rate of 1 ml/min. Buffer F (50 mM 
phosphate (pH 7.4), 100 mM NaCl, 50 mM KCl) 
was used for running buffer. Purity of obtained 
proteins was confirmed by SDS-PAGE (35) . All 
described experiments with PrP  were conducted in 
a biosafety P3** facility. 
CD spectroscopy - A Chirascan CD spectrometer 
(Applied photophysics) and 1 mm cuvette was 
used for all measurements. Far UV spectra 
between 195 and 250 nm were measured at 4 ºC to 
assess the native protein structure. Thermal 
denaturation was monitored by recording the molar 
ellipticity at 222 nm while the sample was heated 
from 4 ºC to 90 ºC at 1 º/min. The sample was 
cooled down and the far UV spectrum was again 
measured at 4 ºC for the refolded protein. The 
respective Tm was calculated according to John et 
al (36). 
Amyloidogenesis of HuPrP under near native 
conditions - The protein was diluted in buffer F to 
the desired concentration (6 µM), ThT was added 
to a concentration of 2 μM and the protein solution 
was aliquoted (100 μl) into the wells of microtiter 
plates (costar NT 96 well, black with clear bottom, 
Corning, USA). The plate was sealed with sealing 
tape. Typically 6 identical samples were prepared 
for each fibrillation experiment. The plate was 
shaken in a Tecan SafireII plate reader at high 
speed in linear mode. Every 15 minutes the 
shaking was halted and fluorescence intensity was 
measured form the bottom of the plate by 
excitation at 440 nm and emission at 480 nm. 
Kinetic traces were fitted according to Almstedt et 
al (35), 2009, to obtain the lag-phase and the 
growth rate for each trajectory. Statistical analysis 
comparing experiments were performed using 
unpaired two tailed t-test using GraphPad Prism 5 
sofware. A p-value <0.05 was considered 
significant. 
Polarization microscopy - Congo red for 
microscopy analysis was added to mature fibrils in 
solution at a molar ratio of fibril:dye 3:1. Stained 
fibrils were left to self-sediment over night at 4 ºC. 
The supernatant was removed and the pelleted 
fibrils were transferred to superfrost plus glass 
slides (Thermo Fisher, Walldorf, Germany), 
covered with Mounting medium (Dako, Glosrup, 
Denmark) and cover glass was sealed with 
transparent nail polish. Congo Red stained samples 
were analysed using a Nikon light microscope 
equipped with polarizers for both incoming light 
and in front of the detector.   
 
RESULTS 
Conformational stability of native HuPrP90-231 129 
mutants - The conformation of the native HuPrP90-
231 protein variants was monitored by far-UV CD 
spectroscopy. All variants displayed a spectrum 
with two negative peaks at 222 and 208 nm 
followed by a positive peak at wavelengths below 
200 nm (Fig 1a). These features are consistent with 
native folded PrP dominated by α–helical structure 
and is in agreement with spectra in the literature 
(37). The thermodynamic stability of the protein 
variants was thereafter monitored by far-UV CD 
spectroscopy. Spectra were recorded at 4 ºC, 
followed by sequential steps of thermal 
denaturation monitored at 222 nm. After complete 
denaturation at 90 ºC, the sample was cooled to 4 
ºC and far-UV CD spectra were recorded again to 
assess any irreversible change of secondary 
structure upon one unfolding-refolding cycle. 
All mutants except 129P showed similar far UV 
CD spectra before denaturation (Fig. 1a). 129P 
displayed decreased positive amplitude between 
195 and 200 nm compared to wt PrP, with a 
concomitant shift of the peak towards 197 nm 
indicating loss of helical structure (38). The 
thermal stability curves of all mutants showed a 
sloping pre-transitional baseline followed by a 
cooperative thermal unfolding transition. 
Comparing the thermal stability of the mutants 
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showed that the 129M, 129V, 129L, 129K and 
129C were the most stable and all within error 
showed Tm’s of 65-66 °C (Fig 1b, Table 1). The 
129A, 129E and 129W mutants were destabilized 
by 3-4 °C and 129P was the most destabilized 
mutant with a Tm lowered by 7.2 °C. After thermal 
denaturation refolding was allowed at 4 °C and the 
reversibility of the thermal unfolding was 
compared. Interestingly the spectral feature of 
129P described above at 197 nm also appeared in 
the spectra for 129W and 129E and, to some 
extent, 129A (Fig. 1c) after refolding. The 129P, 
129W, 129E and 129A mutants were also the most 
destabilized mutants and the amplitude of the 
irreversibility at 195-200 nm correlated well with 
the respective Tm. Traditionally the amount of α–
helix and reversibility of helical structure is easily 
assessed at 222 nm. The reversibility of the CD 
signal at 222 nm for 129C and 129W showed the 
largest difference between the pre-denaturation and 
post-denaturation spectra (Fig 1c), corroborating 
the spectral findings discussed above in the 195-
200 nm region. The difference in molar ellipticity 
at 222 nm in the spectrum before and after thermal 
denaturation was between 9-12 % for stable 
variants and 15-22 % for mutants with lower Tm-
values. One of the most stable variants, 129C, also 
displays the largest loss of helical structure upon 
refolding.  This mutant lost 30% of its helical 
structure upon thermal denaturation-refolding 
(Table 1).  
As a reference for the CD measurements the 
shorter variant HuPrP121-231 (129M) comprising 
only the folded globular domain was employed. 
Comparing the shorter 121-231 construct and 
longer 90-231 construct (HuPrP90-231), the native 
spectrum, the Tm and the reversibility was 
indistinguishable within error for these parameters 
(Table 1), but did reveal a more cooperative 
thermal transition compared to the longer construct 
(Fig 1b). Nevertheless, the identical Tm rules out 
strong interactions between the globular domain 
121-231 with the unstructured partial N-terminal 
90-120 domain on the folding properties of 
HuPrP90-231 in this assay. 
Amyloid fibril formation of HuPrP 129 mutants  - 
Previously we have described in detail that 
vigourous shaking of natively folded PrP in 2 mL 
cryotubes induced protein aggregation and 
amyloidogenesis, in physiological buffer at 37 ˚C 
(35). Aggregates produced according to this 
protocol were collected after 7 h of agitation, 
stained with Congo red and placed on glass slides. 
Imaging with a polarization microscope revealed 
that all mutants except for 129C formed Congo red 
stained birefringent aggregates indicating the 
presence of symmetric Congo red binding sites, the 
tinctorial hallmark of amyloid fibrils (Fig 2a). The 
aggregates of all mutants except for 129C were 
also positive for ThT fluorescence following 
excitation at 440 nm with an emission peak at 485 
nm, which was absent for native protein (Fig. 2b). 
The ThT fluorescence intensity of the fibrils varied 
depending on mutant (Table 2).  
Nonreducing SDS-PAGE of 129C - The lack of 
correlation between thermal stability and refolding 
capability together with the inability to form 
Congo Red and ThT positive fibrils of 129C led us 
to investigate if this was due to intermolecular 
disulfide formation. Aliquots from fibrillation 
reactions of 129M and 129C were collected at 0 
min, 15 min, 2 hours and 4 hours. Samples were 
boiled in non-reducing SDS containing sample 
loading buffer and loaded on SDS-PAGE gels 
followed by Coomassie staining.  The 129M 
variant displayed distinct monomeric band during 
the monitored time course. In the case of 129C, a 
dimeric protein was present already at the initial 
time point. As fibrillation proceeded, the 
monomeric band faded and the dimeric band was 
enhanced (Fig 3). At the end of the time course, a 
faint tetrameric band could also be observed. 
Dimer formation should be caused by 
intermolecular disulfide formation between 
cysteine residues at position 129.    
Amyloid fibrillation kinetics - Formation of 
amyloid fibrils of HuPrP under near physiological 
conditions was monitored by measuring ThT 
fluorescence intensity during the fibrillation 
process in a 96 well plate format. Six separate 
samples of identical composition were used for 
each PrP variant. Every individual trace showed a 
characteristic lag, growth and equilibrium 
trajectory (Fig. 4a, red lines). This is consistent 
with the notion that the amyloid fibrillation process 
of PrP is a nucleation dependent polymerization 
reaction. The ensembles of individual mutant 
trajectories of identical samples revealed that the 
protein showed a rather variable lag-phase 
indicating that PrP fibrillation kinetics is a process 
with a stochastic component which appeared to be 
mutation dependent. This notion is consistent with 
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previous data showing an initial aggregation 
reaction preceding fibril formation which renders a 
kinetic trap from which fibrils protrude  (35). This 
is the background for the variations noted in the 
fibrillation trajectories. Lag times for all mutants 
are listed in Table 3. Comparing lag times during 
the spontaneous fibril formation reaction the 
wildtype-like mutants (129A, 129V and 129L) 
were within the same interval as 129M (~5 h) (Fig 
4a, b, Table 3). Substitutions to conformationally 
constrained  proline, bulky tryptophan or charged 
residues (glutamic acid and lysine) substantially 
elongated the lag time of amyloid formation (Fig 
4b, Table 3). The 129C mutant did not form ThT  
positive fibrils within the time course of the 
experiment (Fig 4a, note the different y-axis, Table 
3).  
The growth phase of the fibril formation 
trajectories was defined as the slope of the ThT 
fluorescence following the end of the lag-phase to 
half the normalized maximum ThT intensity for 
each trajectory (35). In the amyloid fibril formation 
reactions the highest mean growth rates were 
obtained for 129M and 129A.  The clinically 
relevant mutant 129V, known to prolong 
incubation time of prion disease in heterozygote 
carriers and even protect against prion infection, 
had a slower growth rate than the wild type 
(129M) protein (Fig 4a, b, Table 3), (p<0.0001) on 
par with 129W, 129K and 129E.   
The effect of seeding - To investigate the seeded 
fibrillation reactions, 1% seed from previous 
fibrillation reactions were added to fresh protein 
and the fibrillation kinetics was monitored using 
the same setup and analyzing the same parameters 
as for the spontaneous reaction. 
Seeding of the mutants with preformed fibrils of 
the same sequence efficiently shortened the lag 
time for the129M/A/L/V/W/P/E variants (Fig 4a, 
black traces).  The lag time of the 129K mutant 
was unaffected by seeding (Fig 4a,b, Table 3). 
Addition of seed did however induce all samples 
(6/6) to convert into ThT positive fibrils within the 
monitored time frame, whereas only 3/6 samples 
converted spontaneously (Fig 4a,b, Table 3). The 
129C mutant which did not form ThT fluorescent 
fibrils was also unaffected by seeding with 1% 
129C protein subjected to a previous round of 
fibril formation conditions (Fig 4a, note the 
different y-axis, Table 3). Interestingly, addition of 
1 % seed from preformed wild type fibrils (129M) 
did induce formation of ThT positive fibrils of 
129C on the same time scale as the wild type 
protein itself (Fig 4a inset). The strongest seeding 
effect was observed for the 129W and 129P 
mutants and the least affected mutant in terms of 
lag time (129K excluded) was 129V (Fig. 4b). 
Seeding of 129W also showed a prominent effect 
on the growth rate of amyloid formation whereas 
the growth rates for the rest of the studied mutants 
were only modestly affected (Fig 4b, Table 3).  
 
DISCUSSION 
Misfolding of PrPC into PrPSc in the prionoses 
frequently entails the accumulation of PrP 
aggregates with compelling similarities to amyloid 
deposits formed in local and systemic amyloidoses. 
High resolution structural models of PrPSc have 
been presented (39). In two models the PrPC 
molecule is partially refolded starting from the 
unstructured segment (from 90, or 114) up to 
position 175. The PrP molecules are herein 
arranged in intermolecular β–sheet configurations 
(β -helical or spiral), comprising trimeric building 
blocks(40,41). The C-terminal helical domain is to 
a large extent intact in these models. On the 
contrary, there are other more dramatic structural 
rearrangements of misfolded PrP proposed by the 
Surewicz group. Herein, the PrP sequence 
including 90-231 has been shown to be essentially 
completely misfolded in vivo in prion infected 
mice as deduced by hydrogen deuterium exchange 
kinetics (42) into an in-register parallel cross-β–
sheet amyloid state. The structural differences 
between these models and the evidence that 
deposited PrP is conformationally diverse within 
distinct prion strains(43), implicates that 
aggregated PrP is polymorphic. Therefore several 
positions within the PrP sequence should influence 
PrPSc structure and PrPC conversion. In the human 
prion protein the 129 position has been shown to 
constitute the most prevalent single residue linked 
to prion pathogenesis and is known to be 
polymorphic for either M or V. These substitutions 
in position 129 also modulate the HuPrP90-231 
amyloidogenicity under near physiological 
conditions in vitro. The Surewicz group has 
reported that 129V and M have the same fibril 
formation kinetics when subjected to mildly 
denaturing conditions (44). In that study the 
129M/V variants did not fibrillate under native 
conditions when the agitation was slow, in 
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accordance with our previous report on stagnant 
incubation of HuPrP90-231 (129M) (35). 
Nevertheless, studies of the D178N mutation in 
context with either 129M or 129V showed faster 
fibrillation rates both regarding a shorter lag phase 
and faster growth rate when in context with 129M 
(44). This observation is consistent with our data 
on 129M/V in this paper (Table 3), where the  
growth rate for 129V was slower compared to 
129M both for unseeded (0.11 ± 0.06 h-1 vs 0.37 ± 
0.11 h-1) and for self-seeded reactions (0.11 ± 0.02 
h-1 vs 0.44 ± 0.09 h-1) (p<0.0001). In addition the 
lag time for self-seeded 129M (1.5 ± 0.2 h) 
compared to self-seeded 129V (2.9 ± 1.0 h) was 
significantly faster (p<0.005).  
We have herein compared the 
amyloidogenicity and conformational stability of 
nine different recombinant HuPrP90-231 sequences 
with substitutions in position 129 (including M/V) 
to investigate its possible effect on misfolding of 
the protein into the amyloid-like state under near 
native conditions.  
The conformational stability of the 129V, 129L, 
129K and 129C mutations were all within error 
indistinguishable from the wt 129M protein. The 
129A, 129E, 129P and 129W mutants were less 
stable than wt. A possible correlation for the 
destabilization as a consequence of side chain were 
found when comparing the influence on stability 
with the apolar size of the side chain compared to 
the wt 129M (Table 1). Influence of the 
unstructured 90-120 sequence, which has been 
reported to become structured at neutral pH, was 
found to be very low because of indistinguishable 
conformational stability of the HuPrP121-231 and the 
HuPrP90-231 variants. The most severely 
destabilizing mutation was 129P which decreased 
the stability by 7.2 °C. This observation is 
consistent with beta-sheet breaker propensity of 
proline showing that beta-strand 1 is rather 
important for PrP stability. To obtain a reference to 
exemplify the magnitude of destabilization of 
substitutions in position 129 we compared the 
stability results with two previously reported 
highly destabilized disease mutants associated with 
inherited prionoses: H187R (45) and F198S (46). 
When analyzed under the exact same conditions in 
the context of HuPrP90-231 the H187R/129M mutant 
had a Tm of 53.2±0.6 °C and F198S/129M had a 
Tm of 48.6±0.3 °C providing ΔTm:s as compared to 
wt by 12.4 °C and 17.0 °C respectively (Table 1). 
Hence the 129P mutation, although substantial, is 
less destabilizing than these highly destabilized 
naturally occurring pathogenic mutations.  
Congo red birefringence and ThT fluorescence 
showed that eight highly diverse 129-mutants 
formed amyloid fibrils under the conditions used 
herein (intense agitation of folded PrP in 
physiological buffer, at 37 ˚C). In the kinetic 
trajectories (ThT assay) the fibril conversion 
competent mutants showed a lag phase followed 
by a rather steep growth phase which ended in an 
equilibrium phase at the end of the reaction. This 
behavior indicated that the protein regardless of 
substitution in the 129 position displayed nucleated 
polymerization kinetics. This was especially 
evident when the amyloid fibril formation 
reactions were run in the presence of 1% 
preformed PrP fibrils as seeds, which rather 
consistently shortened the lag times. A schematic 
model of the fibril formation reactions is presented 
in Fig 5. Spontaneous fibril formation (Fig. 5 i) is 
initiated by dimerization followed by aggregation 
into oligomeric aggregates that slowly convert to 
amyloid fibrils (35). Fibril seeds added to a new 
fibrillation reaction (Fig. 5 ii) renders direct 
addition and rapid conversion of monomeric PrP. 
In stark contrast to the other eight variants in 
position 129, 129C completely resisted 
spontaneous conversion into amyloid fibrils. 
Investigation of this mutant by non-reducing SDS-
PAGE suggests that this is due to an 
intermolecular disulfide bond formation very early 
in the nucleation process (Fig 3). This, in turn, 
abrogates further nucleation and fibrillation of this 
mutant (Fig 5 iv). Addition of preformed seeds 
from the 129M sequence, however, expediently 
enabled formation of ThT positive fibrils from 
129C sequence. This shows that the wild type 
seeds are able to recruit 129C monomers and 
convert them into the amyloid conformation, hence 
diverting 129C out of the kinetic trap introduced 
by covalent dimerization and places 129C on the 
seeded conversion track (Fig. 5 ii). Importantly, 
dimerization has been shown to be the rate 
determining step in amyloid fibril conversion of 
mPrP albeit under different conditions compared to 
those used in our study (47). Interestingly a dimer 
model within a crystallization interface where the 
beta-stand 1 was paired in an antiparallel 
configuration between two PrP monomers in a co-
crystal complex with an antibody has been 
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reported (48) (Fig 6). This observation supports 
that beta-stand 1 has propensity for inducing 
dimerization of PrP in the native state. Our data 
suggests that this state, if locked in this 
conformation, would be a conversion incompetent 
state. We base that conclusion on all the other 
conversion competent 129 mutations in our study. 
That dramatic conformational reorganization of the 
C-terminal domain follows initial dimerization has 
been shown by structural studies of recombinant 
PrP amyloid fibrils (49) and studies of PrP mutants 
with intramolecular disulfide cross-links within the 
C-terminal domain that efficiently inhibited fibril 
formation (50). Albeit these studies observed PrP 
fibrils formed under denaturing conditions the 
latter study proposes the building block of mPrP 
fibrils to be composed of domain swapped dimers.  
In the spontaneous reaction the lag time of fibril 
formation was rather consistent for all wild type-
like mutants (129A, 129V, 129L). Residues with 
special features like bulkiness (129W), rotational 
constrain (129P) and charge (129E and 129K) 
displayed longer lag times. We speculate that the 
initial aggregation/oligomerization step of the 
conversion reaction is affected by the 129W 
mutation by heightening the barrier of the 
conformational conversion from the oligomeric 
aggregate to amyloid fibril (step 3 in Fig 5 i). The 
pronounced seeding efficiency for the 129W 
mutation strengthens this hypothesis, because this 
trap is circumvented. The 129P mutant showed a 
highly variable lag phase in the spontaneous 
reactions which could reflect different 
conformational populations of proline cis-trans 
isomers during the initial dimerization and 
aggregation steps (steps 1-2 in Fig 5a).  The 129K 
mutant displayed an indifferent lag time when 
seeded, but increased the conversion ratio (Table 
3). This observation in combination with the 
notion that glutamic acid in this position drastically 
shortens the lag time during seeding makes us 
conclude that positive charge – charge repulsions 
in the intermolecular interface of initial 
aggregation is contributing to this alteration and 
hence follows an alternate route of association and 
conversion (step 7 in Fig 5 iii). Hence, the 
recruitment of native monomer to the nuclei 
appears abrogated by positive-charge repulsion 
caused by charged residues exposed on the surface 
of the fibrillation competent conformation. The 
seeding mechanism is distorted. The spontaneous 
reaction is also retarded by positive charge 
repulsion. This positive charge repulsion effect is 
indirectly supported by previous reports on poly-
anion (DNA, RNA, GAG, and LCP) modulation of 
PrP fibril formation and PrPC to PrPSc conversion 
(51-56)).  
Formation of intermolecular disulfides in the 129C 
variant was an early event in aggregation and 
fibrillation (Fig. 5 iv). Hence, arresting the native 
PrP conformation by antiparallel locking of two 
monomers at beta-stand 1 is putatively a strategy 
for intervention of PrP misfolding. The extent of 
the dimerization interface is unlikely to be limited 
to beta-strand 1, but could involve an extended 
portion of PrP. This is currently being investigated 
in our laboratories. Nevertheless, given that a high 
resolution target for an antiparallel arrangement of 
beta-stand 1 in a native state dimer interface  was 
suggested by recent X-ray crystallography data, 
(48) (Figure 6) this could be an exploitable avenue 
for classical drug discovery endeavors. Similar 
small molecule kinetic stabilization of the native 
state has fruitfully been exploited to avoid 
misfolding of the tetrameric protein transthyretin 
(57,58)  
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tryptophan (W), glutamic acid (E), lysine (K) or cysteine (C); GuHCl, guanidine hydrochloride; HuPrP121-
231, human prion protein sequence 121-231, HuPrP90-231, human prion protein sequence 90-231; HuPrP, 
human prion protein; ThT, Thioflavin T. 
 
 
FIGURE LEGENDS 
 
Figure 1. Secondary structure analysis by circular dichroism.  
a) Far UV-circular dichroism spectra of native HuPrP90-231, 129-mutants at 4 °C. Color code for mutant 
identification is shown as inset. 
b) Thermal unfolding curves of 129-mutants monitored at 222 nm. Color code as in Fig 1a). Dashed 
spectrum shows the thermal unfolding curve of  HuPrP121-231129M. 
c) Far UV-circular dichroism spectra of 129-mutants at 4 °C before ( ── ) and after ( - - ) one thermal 
unfolding cycle. 
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Figure 2. Amyloid fibril formation of  HuPrP90-231 mutants. 
a) Micrographs of Congo red stained aggregates of HuPrP90-231, 129-mutants formed under native 
conditions in 2 mL cryotubes. With open (left image) and crossed polarizers (right image). Scale bar 
shows 10 µm. All mutants except for 129C displayed Congored birefringence. A side by side overview 
comparison at lower magnification of 129M and 129C is shown in the lower panel to highlight the lack of 
Congo red stained aggregates from 129C. 
b) Thioflavin T fluorescence spectra of aggregates of HuPrP90-231, 129-mutants formed under native 
conditions. Color code shown as inset. The dashed spectrum shows the fluorescence for native HuPrP90-231 
in the presence of ThT. 
 
Figure 3. Non-reduced denaturing SDS-PAGE of 129C and 129M variants 
Samples taken at different time points during the fibril formation reaction, were boiled in non-reducing 
SDS loading buffer and run on 18% PAGE gels using SDS buffer and the gel was stained with Coomassie. 
The 129C mutant shows the presence of a 35 kDa band (dimer) that increases over time as the 17.5 kDa 
band (monomer) decreases. For the 129M variant only the PrP monomer was detected at all time points. 
The image presented is a composite from duplicate samples run on the same gel (as indicated by dashed 
lines).  
 
Figure 4. Amyloid fibril formation kinetics of HuPrP90-231 mutants. 
a) Normalized kinetic traces (ThT) of amyloid fibril reactions for all investigated mutants monitored for 
24 hours in 96 well plates. Spontaneous reactions displayed in red and the reaction seeded with 1% fibrils 
displayed in black. The kinetic traces of 129C have been related to the intensity of the wild type (129M) 
reaction (note the different y-axis). The inset in the 129C graph shows the kinetics of 129C seeded with 
1% 129M fibrils. n=6 for each reaction. 
b) Amyloid fibril formation kinetic parameters of HuPrP90-231 variants, in absence and presence of 1% seed 
from Fig 4a) (data for 129C not shown). The top panels show lag times and growth rates of the 
spontaneous reactions and the bottom panels show the same parameters for fibrillation reactions seeded 
with 1% fibrils from the same sequence. The average lag times and growth rates were calculated for 
samples that converted within 24 h. 
Color code for mutant identification shown at the bottom of the Figure. The insets in the bottom panels 
show the differences (Δ) of lag time and growth rates compared to spontaneous reactions. 
 
Figure 5. Schematic mechanisms and kinetics of PrP fibril formation evaluated  by amino acid 
substitutions in position 129  
i) Spontaneous fibrillation in the general case. Native HuPrP (position 129 marked in gray) forms a native 
dimer (1) which is further converted into a fibrillation competent misfolded oligomeric aggregate (2). This 
conformational rearrangement is stabilized by intermolecular interactions and exposes different surface 
amino acids than the native protein. The protein further converts into fibrillation nuclei (3) and fibril 
elongation  is initiated (4), followed by fibril fragmentation (5) in the exponential growth phase. 
ii) Seeded reaction. The fibrillation nuclei can directly recruit and convert monomers into the fibrillar state 
(6). 
iii) In the case of 129K, marked in orange, the recruitment of native monomer to the nuclei is abrogated by 
positive-charge repulsion caused by charged residues exposed on the surface of the fibrillation competent 
conformation. The seeding mechanism is distorted. The spontaneous reaction is also to some extent 
delayed by positive charge repulsion (7). 
iv) For 129C the formation of a native dimer enables intermolecular covalent disulfide formation (8) and 
conversion into fibrillation competent conformation is blocked.  
 
Figure 6 A putative dimerization interface of –strand 1  
The structure of HuPrP121-231, highlighting –strand 1 sequence 127-131 (in red) with an intermolecular 
distance of 3.9 Å between neighbouring 129M residues was recently shown by X-ray crystallography The 
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interface was revealed as a crystal packing interaction (48).  Locking the antiparallell configuration of –
strands 1 and 1’ by a disulphide bond in 129C dimer results in a non-convertable state. The structure was 
drawn using the program PyMol using the coordinates 2W9E from pdb. 
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Table 1 
Conformational stability and properties of HuPrP90-231 mutants. 
HuPrP mutant Tm (ºC)a) ∆Tm (ºC)b) Loss of  α-helix % c) 
Accessible non-
polar surface 
area d) 
129M 65.6±0.4 0 12 125.0 
129A 62.4±0.5 -3.1 12 80.4 
129V 66.1±0.4 0.6 9 127.1 
129L 65.8±0.4 0.3 10 156.0 
129P 58.4±0.6 -7.2 15 Nd 
129W 61.5±0.4 -4.1 21 177.2 
129E 61.2±0.4 -4.4 15 57.0 
129K 66.2±0.3 0.7 8 109.3 
129C 65.7±0.4 0.1 30 47.4 
HuPrP121-231129M 65.3±0.2 -0.3 11 Na 
H187R 53.2±0.6 -12.3 27 Na 
F198S 48.6±0.3 -17.0 17 Na 
a) Midpoint of thermal denaturation measured by far UV circular dichroism at 222 nm.  
b) Difference in midpoint of thermal denaturation in comparison to 129M (wt) 
c) Based on change in mean residue ellipticity measured by far UV circular dichroism at 222 nm before and after one 
round of thermal denaturation 4-90 °C. 
d) Data referring to the substituted amino acid obtained from Koh et al,(59) which calculated water-accessible non-
polar surface areas (Å2) of the side chains in the fully extended -form of the peptide Gly-X-Gly, by using the 
Richmond algorithm (60) and van der Waals radii of Richards (61)  
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Table 2 
Tinctorial properties of HuPrP90-231 amyloid fibrils 
HuPrP mutant CR a) ThT b) 
 +/- Intensity, % of wt 
129M + 100 ± 30 
129A + 90 ± 20 
129V + 80 ± 10 
129L + 140 ± 40 
129P + 150 ± 20 
129W + 40 ± 20 
129E + 90 ± 20 
129K + 170 ± 20 
129C - 10 ± 20 
a) Congo red birefringence in crossed polarized light microscopy of fibrils formed after 24h. 
b) ThT fluorescence intensity relative to 129M (wt) set to 100%, using a fluorescence plate reader of fibrils formed 
after 7h in cryo tubes.
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Table 3 
Kinetic parameters of amyloid fibril formation of HuPrP90-231 under near physiological conditions 
assessed by ThT fluorescence. 
All data are means of 6 trajectories with standard deviations. The trajectories were fitted according to Almstedt et al.(35). 
HuPrP mutant lag time (h) growth rate (h-1) Conversion ratioa) 
129M unseeded 4,6 ± 1,1 0,37 ± 0,14 6/6 
129M seeded 1,5 ±  0,2 0,44 ± 0,09 6/6 
129A unseeded 5,3 ± 0,9 0,38 ± 0,13 6/6 
129A seeded 1,6 ±  0,3 0,28 ± 0,03 6/6 
129V unseeded 5,3  ± 1,6 0,11 ± 0,06 6/6 
129V seeded 2,9  ±  1,0 0,11 ± 0,02 6/6 
129L unseeded 5,4 ± 2,0 0,17 ± 0,03 6/6 
129L seeded 2,4  ±  0,1 0,13 ± 0,02 6/6 
129P unseeded 11,8 ± 8,01 0,22 ± 0,06 4/6 
129P seeded 2,6  ±  0,5 0,24 ± 0,18 6/6 
129W unseeded 14,7  ±  2,1 0,10 ± 0,03 6/6 
129W  seeded 2,2 ±  0,2 0,54 ± 0,06 6/6 
129E unseeded 10,3  ±  1,0 0,14 ± 0,07 6/6 
129E seeded 3,4 ±  0,7 0,13 ± 0,02 6/6 
129K unseeded 8,3 ±  0,3 0,11 ± 0,05 3/6 
129K seeded 10,4 ± 2,4 0,15 ± 0,06 6/6 
129C unseeded >24h n.d. 0/6 
129C seeded >24h n.d. 0/6 
129C seeded with wt 2,6 ± 0,7 0,15 ± 0,02 6/6 
a) Samples/total number of samples that displayed ThT fluorescence within 24 h. 
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